About Invizius
Invizius is a company based in Edinburgh (United Kingdom) founded in 2018. Invizius has raised $13.09 million across 6 funding rounds from investors including Mercia, Downing and Scottish Enterprise. The company has 12 employees as of December 31, 2021. Invizius offers products and services including H-Guard and PspCN. Invizius operates in a competitive market with competitors including VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 12 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invizius Limited
- Date of Incorporation 26 Jan, 2018
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.09 M (USD)
in 6 rounds
-
Latest Funding Round
$1.27 M (USD), Series A
Sep 23, 2024
-
Investors
Mercia
& 9 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invizius
Invizius offers a comprehensive portfolio of products and services, including H-Guard and PspCN.
Complement therapy for patients on dialysis and extracorporeal circuits.
Technology to supercharge natural regulators for enhanced efficacy.
Funding Insights of Invizius
Invizius has successfully raised a total of $13.09M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.27 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invizius
Invizius has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Mercia, Downing and Scottish Enterprise.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Locked | Locked | Locked |
Investor details for Invizius
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invizius
Investment portfolio details for Invizius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invizius
Detailed financials for Invizius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invizius Comparisons
Peer comparison for Invizius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invizius
Invizius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Shape memory polymer stents are developed for vascular surgery applications.
|
|
| Locked | Locked | Locked |
Sorbents for renal replacement therapy are developed using regenerative technology.
|
|
| Locked | Locked | Locked |
Blood access is monitored during hemodialysis via alarm systems.
|
|
| Locked | Locked | Locked |
Contract Manufacturer of Dialysis products, Also sells own product lines.
|
|
| Locked | Locked | Locked |
Develops innovative renal dialysis machines with soundproof boxes.
|
Detailed competitors of Invizius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invizius
Complete news archive for Invizius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invizius
Invizius was founded in 2018.
Invizius is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Richard Boyd is the current CEO of Invizius.
Invizius is a funded company, having raised a total of $13.09M across 6 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Invizius is 12.
Invizius was founded in 2018 in Edinburgh, United Kingdom, within the medical devices sector focused on dialysis technology. Priming solutions for hemodialyzers are developed by the company, with H-Guard as the primary product under development. This solution incorporates a hemocompatible coating to mitigate foreign body reactions in blood during dialysis procedures. Applications target hollow fibers in dialyzers, where membrane inflammation in patients blood is addressed through reduced interactions.
Invizius's top competitors include VenoStent, Redsense Medical and Renal Solutions.
Invizius offers H-Guard and PspCN.
Invizius has 10 investors. Key investors include Mercia, Downing, Scottish Enterprise, Calculus Capital, and Solvay.